cagrilintide phase 3 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Presenters to provide first look

Sarrabayrouse et al

Functional improvements like increased range of motion and reduced inflammation typically appear in weeks 2-3

Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months

Key Features: Product Name: Bacteriostatic Water Composition: Sterile Water for Injection with 0.9% Benzyl Alcohol CAS Number: 8000-34-8 (Benzyl Alcohol) Sterility: Sterile / Non-pyrogenic Physical Form: Liquid solution Intended Use: Reconstitution and dilution of research compounds Storage Conditions: Store at controlled room temperature (6877F / 2025C)

Second, injection technique matters

The research base is real